Jaroslav Štěrba

7.0k total citations
148 papers, 1.7k citations indexed

About

Jaroslav Štěrba is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jaroslav Štěrba has authored 148 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 39 papers in Oncology and 25 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jaroslav Štěrba's work include Acute Lymphoblastic Leukemia research (23 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Glioma Diagnosis and Treatment (16 papers). Jaroslav Štěrba is often cited by papers focused on Acute Lymphoblastic Leukemia research (23 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Glioma Diagnosis and Treatment (16 papers). Jaroslav Štěrba collaborates with scholars based in Czechia, United States and Germany. Jaroslav Štěrba's co-authors include Renata Veselská, Pavel Mazánek, Karel Zitterbart, Dalibor Valík, Petr Chlapek, Jakub Neradil, Zdeněk Pavelka, Peter Múdrý, Viera Bajčiová and Regina Demlová and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Jaroslav Štěrba

136 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaroslav Štěrba Czechia 22 604 469 252 238 219 148 1.7k
Patrick Lutz France 26 374 0.6× 490 1.0× 269 1.1× 264 1.1× 462 2.1× 62 2.3k
Belinda Pinto Simões Brazil 27 484 0.8× 519 1.1× 196 0.8× 101 0.4× 274 1.3× 137 2.8k
D Niethammer Germany 21 392 0.6× 282 0.6× 122 0.5× 416 1.7× 199 0.9× 96 1.5k
Esa Jantunen Finland 23 239 0.4× 861 1.8× 181 0.7× 155 0.7× 181 0.8× 73 2.0k
Tomasz Wróbel Poland 22 560 0.9× 567 1.2× 173 0.7× 96 0.4× 99 0.5× 198 1.9k
Tracy L. Bergemann United States 21 730 1.2× 447 1.0× 303 1.2× 67 0.3× 160 0.7× 36 2.4k
Aks Chiang Hong Kong 35 457 0.8× 1.7k 3.6× 151 0.6× 211 0.9× 160 0.7× 121 3.0k
Kimo C. Stine United States 22 323 0.5× 315 0.7× 332 1.3× 192 0.8× 103 0.5× 59 1.4k
Morris Kletzel United States 29 922 1.5× 479 1.0× 447 1.8× 624 2.6× 384 1.8× 148 3.1k
Julián Sevilla Spain 26 528 0.9× 485 1.0× 260 1.0× 166 0.7× 162 0.7× 130 2.3k

Countries citing papers authored by Jaroslav Štěrba

Since Specialization
Citations

This map shows the geographic impact of Jaroslav Štěrba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaroslav Štěrba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaroslav Štěrba more than expected).

Fields of papers citing papers by Jaroslav Štěrba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaroslav Štěrba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaroslav Štěrba. The network helps show where Jaroslav Štěrba may publish in the future.

Co-authorship network of co-authors of Jaroslav Štěrba

This figure shows the co-authorship network connecting the top 25 collaborators of Jaroslav Štěrba. A scholar is included among the top collaborators of Jaroslav Štěrba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaroslav Štěrba. Jaroslav Štěrba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kepák, Tomáš, et al.. (2024). Socioeconomic status and adiposity in childhood cancer survivors: A cross-sectional retrospective study. PLoS ONE. 19(2). e0298068–e0298068. 1 indexed citations
2.
Štourač, Jan, Petra Pokorná, Joan Planas-Iglesias, et al.. (2023). PredictONCO: a web tool supporting decision-making in precision oncology by extending the bioinformatics predictions with advanced computing and machine learning. Briefings in Bioinformatics. 25(1). 3 indexed citations
3.
Selingerová, Iveta, et al.. (2022). Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients. Current Oncology. 29(6). 4138–4147. 2 indexed citations
4.
Pokorná, Petra, Giannoula Klement, Veronika Kanderová, et al.. (2022). Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing. JCO Precision Oncology. 6(6). e2100525–e2100525. 2 indexed citations
5.
Štěrba, Jaroslav, et al.. (2021). Development of the Czech Childhood Cancer Information System: Data Analysis and Interactive Visualization. JMIR Public Health and Surveillance. 7(6). e23990–e23990. 2 indexed citations
6.
Škoda, J., Jakub Neradil, Petr Chlapek, et al.. (2020). Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms. Cancers. 12(12). 3781–3781. 8 indexed citations
7.
Mazánek, Pavel, et al.. (2018). Life threatening hypoglycaemia in a child with infantile myofibromatosis. 32(2). 33–37.
8.
Dubská, Lenka Zdražilová, Peter Múdrý, Pavel Mazánek, et al.. (2017). Immunomonitoring of patients treated with personalized dendritic cell-based vaccine. Annals of Oncology. 28. xi17–xi17. 2 indexed citations
9.
Dubská, Lenka Zdražilová, Eva Hlaváčková, Eva Matoulková, et al.. (2016). TKI pazopanib impaires immunostimulatory properties of monocytes: Implication for monocyte-derived DC-based anti-cancer vaccine preparation. Annals of Oncology. 27. viii6–viii6. 1 indexed citations
10.
Obermannová, Radka, Ladislav Dušek, Jiří Jarkovský, et al.. (2015). Time-course pattern of blood 25-hydroxycholecalciferol is a significant predictor of survival outcome in metastatic colorectal cancer: a clinical practice-based study. Neoplasma. 62(6). 958–965. 7 indexed citations
11.
Tůma, Jiří, et al.. (2014). Inflammatory Myofibroblastic Tumor of the Esophagus in Childhood. Journal of Pediatric Hematology/Oncology. 37(2). e121–e124. 9 indexed citations
12.
Vašků, Julie Bienertová, Lenka Zdražilová Dubská, Radka Obermannová, et al.. (2013). Vitamin D – jeho fyziologie, patofyziologie a význam vetiopatogenezi nádorových onemocnění. 152(1).
13.
Vašků, Julie Bienertová, Filip Zlámal, Josef Tomandl, et al.. (2012). BAFF Levels Are Elevated in Paediatric Patients With Acute Lymphoblastic Leukaemia Compared to Other B-Lineage Neoplasms. 1(1). 20–22. 3 indexed citations
14.
Blatný, Marek, Tomáš Kepák, Martin Jelínek, et al.. (2011). Quality of life of childhood cancer survivors: handicaps andbenefits. ASEP. 55(2). 4 indexed citations
15.
Mejstříková, Ester, Eva Froňková, Tomáš Kalina, et al.. (2010). Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria. Haematologica. 95(6). 928–935. 42 indexed citations
16.
Kepák, Tomáš, Marek Blatný, Martin Jelínek, et al.. (2008). Následky léčby dětských nádorových onemocnění v oblasti neurokognitivních funkcí a jejich vliv na kvalitu života.. Pediatrie pro praxi. 8(6). 353–357. 1 indexed citations
17.
Blatný, Marek, et al.. (2007). Kvalita života dětí po léčbě nádorového onemocnění: současnépoznatky a směry výzkumu.. 42(4). 1 indexed citations
18.
Valík, Dalibor, Martin Radina, Jaroslav Štěrba, & Bořivoj Vojtěšek. (2006). Homocysteine: a promising biomarker of folate antagonist chemotherapy. 14(2). 75–83. 1 indexed citations
19.
Štěrba, Jaroslav & Iva Dyková. (1978). Tissue reaction of the liver of cattle to an artificial or natural infection with Cysticercus bovis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(2). 143–6. 2 indexed citations
20.
Hulínská, D, et al.. (1977). Experimental studies on bovine cysticercosis. Acta Parasitologica Polonica. 25. 55–62. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Lutz Breakdown of academic impact, for papers by Belinda Pinto Simões Breakdown of academic impact, for papers by D Niethammer Breakdown of academic impact, for papers by Esa Jantunen Breakdown of academic impact, for papers by Tomasz Wróbel Breakdown of academic impact, for papers by Tracy L. Bergemann Breakdown of academic impact, for papers by Aks Chiang Breakdown of academic impact, for papers by Kimo C. Stine Breakdown of academic impact, for papers by Morris Kletzel Breakdown of academic impact, for papers by Julián Sevilla
Rankless by CCL
2026